Scandinavia: insight into opportunities for drug discovery
Drug Discovery World
FEBRUARY 10, 2023
The weakness connected to that is we have so few large pharmaceuticals. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.”
Let's personalize your content